SCHEMBL8771130

SCHEMBL8771130

C=C(C)C(=O)NC(C)N1CCCC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA3 P07451 1/20 0.43
CA4 P22748 1/20 0.43
CA6 P23280 1/20 0.43
CA5A P35218 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA13 Q8N1Q1 1/20 0.43
CA14 Q9ULX7 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
PIK3CD O00329 1/20 0.38
RXFP1 Q9HBX9 1/20 0.37
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19146906 0.94 LMNA (0.38) LMNACA12CA1CA2CA3
SCHEMBL23343657 0.83 LMNA (0.47) LMNACA12CA1CA2CA3
SCHEMBL11478534 0.82 LMNA (0.49) LMNACA12CA1CA2CA3
SCHEMBL9397107 0.78 TSHR (0.47) LMNACA12CA1CA2CA3
SCHEMBL19146573 0.76 LMNA (0.41) LMNACA12CA1CA2CA3
SCHEMBL295308 0.75 TGFBR1 (0.33) RXFP1CHRM5CHRM3TGFBR1
Methacrylic Acid SCHEMBL1817343 0.74 LMNA (0.45) LMNACA12CA1CA2CA3
SCHEMBL22562961 0.74 LMNA (0.42) LMNACA12CA1CA2CA3
SCHEMBL4154528 0.73 LMNA (0.44) LMNACA12CA1CA2CA3
SCHEMBL22847870 0.73 MAPT (0.37) LMNAKMT2ATGFBR1TSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5037930-A Heterocyclic quaternized nitrogen-containing cellulosic graft polymers GAF CHEMICALS CORPORATION (US) 1991-08-06 US claimed
US-11912831-B2 Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers ISP INVESTMENTS LLC (US) 2024-02-27 US disclosed
US-11912831-B2 Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers ISP INVESTMENTS LLC (US) 2024-02-27 US disclosed
US-11859029-B2 Methods of synthesis of homopolymers and non-homopolymers comprising repeating units derived from monomers comprising lactam and acryloyl moieties in an aqueous medium ISP INVESTMENTS LLC (US) 2024-01-02 US disclosed
US-11859029-B2 Methods of synthesis of homopolymers and non-homopolymers comprising repeating units derived from monomers comprising lactam and acryloyl moieties in an aqueous medium ISP INVESTMENTS LLC (US) 2024-01-02 US disclosed
US-11001751-B2 Crosslinked polymers derived from monomers having acryloyl and lactam moieties and sulfonic acid/sulfonate comonomers, compositions thereof, and applications thereof HERCULES LLC (US) 2021-05-11 US disclosed
US-20200407470-A1 METHODS OF SYNTHESIS OF HOMOPOLYMERS AND NON-HOMOPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES IN AN AQUEOUS MEDIUM ISP INVESTMENTS LLC (US) 2020-12-31 US disclosed
US-10876015-B2 Coating compositions for forming toner coatings ISP INVESTMENTS LLC (US) 2020-12-29 US disclosed
US-10865264-B2 Hydroxyethylpyrrolidone methacrylate/glycidyl methacrylate copolymers ISP INVESTMENTS LLC (US) 2020-12-15 US disclosed
US-10844154-B2 Proliferous copolymers comprising lactamic moieties ISP INVESTMENTS LLC (US) 2020-11-24 US disclosed
US-10765617-B2 Personal care compositions comprising copolymers of cationic monomers and acryloyl lactam based monomers, process for the same and method of use ISP INVESTMENTS LLC (US) 2020-09-08 US disclosed
US-10745502-B2 Polymers for oral care compositions ISP INVESTMENTS LLC (US) 2020-08-18 US disclosed
US-10632059-B2 Non-aqueous compositions of polymers derived from monomers having acryloyl moiety and lactam moiety and applications thereof ISP INVESTMENTS LLC (US) 2020-04-28 US disclosed
US-20190382519-A1 CROSS-LINKED BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES, COMPOSITIONS, AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2019-12-19 US disclosed
US-20190151224-A1 PERSONAL CARE COMPOSITIONS COMPRISING COPOLYMERS OF CATIONIC MONOMERS AND ACRYLOYL LACTAM BASED MONOMERS, PROCESS FOR THE SAME AND METHOD OF USE ISP INVESTMENTS LLC (US) 2019-05-23 US disclosed
US-20190015304-A1 BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHOBIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2019-01-17 US disclosed
WO-2017123572-A1 BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHOBIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2017-07-20 WO disclosed
EP-0572977-B1 Bilirubin assay using crosslinkable polymers JOHNSON & JOHNSON CLIN DIAG (US) 1997-08-13 EP disclosed
US-4956432-A Hydrophilic transparent crosslinked copolymer and the method for producing thereof CESKOSLOVENSKA AKADEMIE VED (CS) 1990-09-11 US disclosed
EP-0345794-A2 Hydrophilic transparent crosslinked copolymers and method for their preparation CESKOSLOVENSKA AKADEMIE VED (CS) 1989-12-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10745502-B2 Polymers for oral care compositions SMARCC1, MPO, ARID2 LMNA 1522/4885CA12 3095/4885CA1 1595/4885
US-11912831-B2 Hydroxyethylpyrrolidone ethacrylate/glycidyl ethacrylate copolymers MMAB, PCNA, HMBS LMNA 2499/4885CA12 1204/4885CA1 867/4885
US-10632059-B2 Non-aqueous compositions of polymers derived from monomers having acryloyl moiety and lactam moiety and applications thereof C9, PARG, C5 LMNA 154/4885CA12 3093/4885CA1 2470/4885
US-20190015304-A1 BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHOBIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF F9, ADCY9, MMS19 LMNA 2191/4885CA12 2531/4885CA1 3645/4885
US-11001751-B2 Crosslinked polymers derived from monomers having acryloyl and lactam moieties and sulfonic acid/sulfonate comonomers, compositions thereof, and applications thereof CAD, STS, COASY LMNA 1683/4885CA12 1078/4885CA1 296/4885
US-10844154-B2 Proliferous copolymers comprising lactamic moieties PCNA, MKI67, CCNA1 LMNA 1224/4885CA12 1456/4885CA1 1980/4885
US-10765617-B2 Personal care compositions comprising copolymers of cationic monomers and acryloyl lactam based monomers, process for the same and method of use AADAC, KRT18, AAAS LMNA 2031/4885CA12 1202/4885CA1 615/4885
US-20190382519-A1 CROSS-LINKED BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES, COMPOSITIONS, AND APPLICATIONS THEREOF ADSL, ABHD6, APH1B LMNA 2576/4885CA12 2511/4885CA1 4103/4885
US-20190151224-A1 PERSONAL CARE COMPOSITIONS COMPRISING COPOLYMERS OF CATIONIC MONOMERS AND ACRYLOYL LACTAM BASED MONOMERS, PROCESS FOR THE SAME AND METHOD OF USE AADAC, KRT18, AAAS LMNA 2031/4885CA12 1202/4885CA1 615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.